Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people on tirzepatide notice food tastes saltier, more metallic, or simply different from how it used to. This is a real and reported phenomenon, not imagination. Changes in taste perception have been observed with GLP-1 and dual-agonist medicines, though they are not among the most commonly listed side effects in the NHS patient information for tirzepatide. If your meals suddenly taste odd, here is what the evidence suggests and what to watch for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You have been on Mounjaro for a few weeks. Appetite is down, which you expected. What you did not expect is that your favourite meal now tastes oddly salty, or slightly metallic, or just flatter than usual. It is a disorienting experience, and it is understandable to wonder whether the medicine is doing something strange to your senses.
The honest answer is that taste changes with tirzepatide are real but not fully explained yet. They appear in patient-reported data and in clinical communities, though they were not a primary outcome in the major trials. The NHS tirzepatide page does not list saltiness specifically among the known side effects, which are led by gastrointestinal symptoms such as nausea, vomiting, and changes in bowel habit. That does not mean your experience is wrong, it means it sits in the less-studied corner of a medicine that is still under additional MHRA monitoring as a Black Triangle product.
One plausible mechanism: GIP and GLP-1 receptors are found not only in the gut but in regions of the brain that process reward and flavour. Tirzepatide activates both. It is reasonable to think that activating those pathways alters how the brain weighs up sensory signals from food, including the balance of salt, sweet, and umami. Some researchers have noted that GLP-1 agonists appear to dampen the reward signal food normally produces, which could translate as food tasting less rich or more one-dimensional rather than genuinely saltier. The perception of saltiness could reflect that shift.
It helps to separate two distinct effects people describe. The first is a genuine change in taste perception: food triggers a different sensory signal than expected, often described as salty, metallic, or bland. The second is a change in food preference: foods that once felt rewarding (particularly high-fat or high-sugar items) no longer hold the same appeal.
The second effect is much better documented. Across patient surveys and the clinical trial programme, a meaningful proportion of people on tirzepatide report spontaneously shifting away from ultra-processed foods and toward plainer options. That shift is partly appetite-related and partly a change in what the brain finds satisfying. Our page on how Mounjaro affects your relationship with food covers this in more depth.
The saltiness question may sit at the intersection of both effects. If your brain is no longer amplifying the pleasure of sweet and fatty foods, salt may become more prominent by comparison, not because more salt is reaching your taste buds, but because the other flavour signals have quietened. It is a perceptual shift, not a physiological one in the traditional sense. That said, a small number of people do report a genuinely metallic or mineral quality to food that goes beyond preference change, and this warrants attention if it persists.
If the change is affecting how much you eat (either because food is less enjoyable or because certain textures feel wrong) read our guidance on what to eat while on Mounjaro for practical ideas on keeping nutrition solid when appetite and taste are both shifted.
A mild, temporary change in how food tastes is not dangerous. Most people who notice it find it settles within a few weeks, particularly after the body adjusts to a new dose. The MHRA and the medicine's SmPC do not flag taste disturbance as a reason to stop treatment, but they do ask prescribers and patients to monitor and report unexpected effects, which is part of why the Black Triangle designation exists for newer medicines like tirzepatide.
Situations that deserve a conversation with your prescriber: taste changes that make eating unpleasant enough to reduce your food intake significantly; a metallic taste that arrives suddenly and is accompanied by severe stomach pain (which could signal something unrelated but worth checking); or any change that is getting worse rather than settling. You can also report unexpected effects directly through the MHRA's Yellow Card scheme, which helps build the evidence base for medicines still accumulating real-world data.
Separately, some people wonder whether changes in taste are connected to other sensory side effects. If you have noticed more perspiration since starting treatment, our page on whether Mounjaro makes you sweat more than usual looks at what the evidence says and how this fits alongside other unexpected physical changes. Changes in breath have also come up in patient discussions; our page on whether Mounjaro affects breath addresses that honestly.
Taste is not the only unexpected food-related effect. Some people find hunger behaves in less predictable ways than they expected. If that resonates, whether Mounjaro can make you hungry unpacks that paradox clearly.
Mounjaro is a prescription-only medicine. Any decision about your dose, your treatment plan, or whether to continue is made by your prescriber, not adjusted based on symptoms alone. If you have not yet started treatment and are exploring whether tirzepatide could be right for you, check your eligibility through a free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.